NCT00558857

Dynamic Substrate Mapping (DSM) for Ischemic VT

Clinical Feasibility of Using Dynamic Substrate Mapping to Guide Ablation of Ischemic Ventricular Tachycardia

• Status: Terminated
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, non-randomized study to determine the feasibility of using a new technique called Dynamic Substrate Mapping (DSM) to help guide the treatment of ischemic ventricular tachycardia (IVT). We hypothesize that DSM will lead to simpler, more effective ablation of IVT. Results from this study will be used to determine if further clinical investigation is warranted.

Conditions

• Ischemic Ventricular Tachycardia

Interventions

Type	Name	Description
DEVICE	Dynamic Substrate Mapping-guided ablation	Radiofrequency ablation

Timeline

• Start date: 2007-07-01
• Primary completion: 2009-04-01
• Completion: 2009-04-01
• First posted: 2007-11-15
• Last updated: 2019-02-04

Locations

3 sites across 1 country: United States